Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Retinal Vein Occlusion

• A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macu
• Cool vs Room-temperature Artificial Tears
• A Phase III Study for 601 Versus Ranibizumab in Patients With Branch Retinal Vein Occlusion (BRVO)
• Custom Needle Preparation for Suprachoroidal Steroid Injection (One Year Results)
• Formulated PSTA Injection Versus PATA Alone in the Management of Macular Edema Secondary to Non-ischemic Retinal Vein Occlusions
• Efficacy of Formulated Posterior Sub Tenon Triamcinolone in Macular Edema Secondary to Non-Ischemic Retinal Vein Occlusions
• Comparison of Combined Intravitreal Bevacizumab and Oral Acetazolamide Versus Intravitreal Bevacizumab Alone for the Treatment of Macular Edema Secondary to Retinal Vein Occlusions
• Ranibizumab Versus Aflibercept for CRVO in Young Patients.
• NIR Fluorescence Molecular Imaging of ANXV-800CW in RVO Patients
• EffiCacy, Safety and ToLErability of a Novel Ocular ANtiseptic for Ocular Use (CLEAN)
• The Use of Suprachoroidal Triamcinolone Acetonide to Treat Macular Edema in Retinal Vein Occlusion
• Comparison of Intravitreal Anti-VEGF Versus Combination Therapy in Central Retinal Vein Occlusion
• Spontaneous Retinal Artery Pulses (SPARs) as a Prognostic Determinant of Central Retinal Vein Occlusions (CRVO) in Patients With or Without Intravitreal Aflibercept Injections
• A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion
• A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion
• Vascular Endothelial Growth Factor (VEGF) Levels in Retinal Vein Occlusion (RVO) During Anti-VEGF Treatment
• 601 Versus Ranibizumab in Patients With Central Retinal Vein Occlusion (CRVO)
• 601 Versus Ranibizumab in Patients With Branch Retinal Vein Occlusion (BRVO)
• A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients
• Central Retinal Vein Occlusion (CRVO) Treatment With Bevacizumab and Dexamethasone or Bevacizumab Only.
• Branch Retinal Vein Occlusion (BRVO) Treatment With Bevacizumab and Dexamethasone or Bevacizumab Only.
• A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO)
• Safety and Efficacy of IBE-814 Intravitreal (IVT) Implant - A Sustained, Low Dose Dexamethasone Therapy
• Effect on Pain and Inflammation With DEXTENZA Treatment in Patients Undergoing Intravitreal Anti-VEGF Injections
• Combination of Ranibizumab and Targeted Laser Photocoagulation
• Use of Ziv Aflibercept in Different Retinal Diseases
• Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole
• Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole
• A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Diabetic Macular Edema and Retinal Vein Occlusion
• Ranibizumab Treatment for Macular Edema Secondary to Retinal Vein Occlusion
• Post Intravitreal Injection Topical NSAID vs. Patching
• Evaluation of OZURDEX® in Patients With Macular Edema Secondary to Retinal Vein Occlusion in China
• Bevacizumab Versus DEX Implant Followed by Bevacizumab in ME Secondary to BRVO
• Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion
• Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion
• Exploratory Study to Investigate the Bioactivity, Ocular and Systemic Safety, Tolerability, and Pharmacokinetics Following Single and Multiple Intravitreal Administrations of KSI-301 in Subjects With wAMD, DME and RVO
• Study Assessing AR-1105 in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)
• Eylea and Lucentis for Macular Edema in Branch Retinal Vein Occlusion
• Navigated Laser In Branch Retinal Vein Occlusion Study
• Surgical Stabilizer Assisted RVC With rtPA for CRVO
• Prospective Trial of Treat and Extend Aflibercept for Macular Edema Secondary to Branch Retinal Vein Occlusion
• Combined Intravitreal Injection of Bevacizumab and Fasudil Versus Bevacizumab Alone for Macular Edema Secondary to Retinal Vein Occlusion in Previously Treated Patients
• Comparison of Therapeutic Effects Between Intravitreal Injection of Bevacizumab With Intravitreal Injection of Bevacizumab and Targeted Laser Photocoagulation of Non Perfused Areas of Retina in Patients With Acute Retinal Vein Occlusion
• Conbercept Ophthalmic Injection for Patients of Central Retinal Vein Occlusion
• Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Following RVO
• Conbercept Ophthalmic Injection for Patients With Macular Edema Caused by Branch Retinal Vein Occlusion
• TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)
• Cytokine and Visual Outcome Variations in Eyes Receiving Ranibizumab
• Cytokine and Visual Outcome Variations in Eyes Receiving Aflibercept
• Combination of Intravitreal Ranibizumab With or Without Macular Laser Photocoagulation for ME Secondary to BRVO
• Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO
• Prevention of Retinal Non-perfusion in Central Retinal Vein Occlusion by Hydroxycarbamide Treatment.
• Trial of Aganirsen in iCRVO Patients at Risk of Developing NVG
• A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA651 in Patients With Macular Edema
• Evaluation of a Treat and Extend Regimen of Intravitreal Aflibercept for Macular Edema Secondary to CRVO
• Phase I RVC With Ocriplasmin for CRVO
• A Study in Patients With Neovascular Age Related Macular Degeneration or Macular Edema Secondary To Retinal Vein Occlusion to Evaluate Usability of the Ranibizumab (Lucentis®) Prefilled Syringe (PFS)
• Retrospective Data Analysis of Patients Treated for Macular Edema Due to Central Retinal Vein Occlusion
• Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein Occlusion
• Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept in Canada
• Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME.
• Intravitreal Injections of Ziv-aflibercept for Macular Diseases
• Retinal Sensitivity in BRVO After Anti-VEGF Therapy
• Evaluation of the "Treat-and-extend" Scheme in Patients With Retinal Vein Occlusion (RVO) With and Without LASER Treatment of Ischaemic Retinal Areas
• Peripheral and Macular Retinal Vascular Perfusion and Leakage in DME and RVO
• Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection
• Evaluation of the Usefulness of a PRN Regimen Using Ranibizumab for Macular Edema Due to Branch Retinal Vein Occlusion
• Open Label Study to Assess the Efficacy and Safety of AKB-9778 in Subjects With Macular Edema Due to RVO
• Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO
• Comparing Injection Frequency Between Aflibercept and Ranibizumab in Patients With CRVO With a Treat& Extend Regimen
• Exploratory Study of KPI-121 Effect on Intra- or Subretinal Fluid Due to Retinal Vein Occlusion/Diabetic Macular Edema
• Ziv-aflibercept in Eyes With Retinal Diseases and Poor Vision-phase I
• Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein Occlusion
• Prognostic Factors for Visual Improvement in Patients Undergoing Intravitreal Ranibizumab for Retinal Vein Occlusion
• Efficacy and Safety of Lucentis® (Ranibizumab Intravitreal Injections) in Chilean Patients With Diabetic Macular Edema.
• Systemic Pharmacokinetics Following Intravitreal Injections of Anti-VEGF
• Predictive Factors of Ranibizumab Treatment in Macular Edema With CRVO
• Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Eylea for Central Retinal Vein Occlusion (CRVO)
• Long-term Treatment Effect of Intravitreal Ant-VEGF in Branch Retinal Vein Occlusion
• Phase 1 Open-label Study to Evaluate Efficacy and Tolerability of TLC399 in Patients With Macular Edema Due to RVO
• Safety and Efficacy of Dexamethasone (OZURDEX®) Intravitreal Implant in Korea
• Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO)
• Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Central Retinal Vein Occlusion (CRVO)
• Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2)
• Ranibizumab Treatment for Retinal Vein Occlusion
• Proof of Concept Study of Re-treatment in BRVO With Ranibizumab Guided by OCT
• Ozurdex Implant for Macular Edema After Treatment Failure With Anti-VEGF
• A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema
• A Safety and Efficacy Study of OZURDEX® in Macular Edema Associated With Branch Retinal Vein Occlusion
• NEWTON: Aflibercept Injection for Previously Treated Macular Edema Associated With Central Retinal Vein Occlusions
• Study of Intravitreal Aflibercept Injection for Persistent CRVO-associated Macular Edema Despite Prior Anti-VEGF Therapy
• Ozurdex Versus Ranibizumab Versus Combination for Central Retinal Vein Occlusion
• Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Fair Vision
• Ozurdex for Retinal Vein Occlusion Study (ORVO Study)
• Dexamethasone-implant for the Treatment of RVO
• Impact of Intravitreal Aflibercept Injections on Capillary Non-Perfusion
• Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion
• Safety and Efficacy Study of Dexamethasone in the Treatment of Patients With Macular Edema Following Retinal Vein Occlusion (RVO)
• Anesthesia Preference for Intravitreal Injection: Topical or Subconjunctival
• Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Retinal Vein Occlusions (BRVO)
• Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein Occlusion
• Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein Occlusion
• Intra-arterial Thrombolysis for Severe Recent Central Retinal Vein Occlusion
• Ozurdex With Rescue Lucentis for Treating Macular Edema Secondary to Retinal Vein Occlusion
• Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO
• Extension Study to Gather Data on Effect of Macugen on the Corneal Endothelium
• A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO)
• Retrospective Data Collection Study in Patients Receiving Two or More OZURDEX® Injections for Macular Oedema Secondary to Retinal Vein Occlusion
• A Long-Term Safety Study of OZURDEX® in Clinical Practice
• Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion
• Study to Assess the Clinical Efficacy and Safety of Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) in Patients With Branch Retinal Vein Occlusion (BRVO)
• Efficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion (HIKARI)
• Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab
• Minocycline to Treat Central Retinal Vein Occlusion
• Minocycline to Treat Branch Retinal Vein Occlusion
• Efficacy of an Intravitreal DEX Implant in Retinal Vein Occlusion Following Treatment With Anti-VEGF Injections.
• Hemodilution Versus Ranibizumab in Early-onset Central Retinal Vein Occlusion
• A Retrospective Data Collection Study in Patients Receiving Dexamethasone Intravitreal Implant (Ozurdex®) for Macular Oedema Due to Retinal Vein Occlusion (RVO)
• An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2)
• Bevacizumab Versus Ranibizumab in Treatment of Macular Edema From Vein Occlusion
• Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion
• Retrospective Study in Patients Receiving Two or More OZURDEX® Injections for Retinal Vein Occlusion (RVO)
• Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)
• Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)
• Efficacy and Safety of Ranibizumab in Japanese Patients With Retinal Vein Occlusion
• Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
• Effect of Ozurdex® 0.7 mg on Improvement of Efficacy of Bevacizumab for Central Retinal Vein Occlusion
• A Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein Occlusion
• REtinal Vein OccLUsion Treatment With Scatter Laser Guided by UWFA in combiNAtion With Ranibizumab Study
• Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO)
• Study of 2.0 mg Ranibizumab in Subjects With Ischemic Central Retinal Vein Occlusion (RAVE2)
• Extended Follow-up of Patients With Macular Edema Due to Retinal Vein Occlusion
• Comparison of Intravitreal Ranibizumab and Macular Laser Photocoagulation for ME Following Branch Retinal Vein Occlusion (BRVO)
• Intravitreal Bevasizumab Versus Intravitreal Triamcinolone in Central Retinal Vein Occlusion (CRVO)
• Efficacy and Safety of Lucentis for Clinically Significant Macular Edema Secondary to Central Retinal Vein Occlusion
• Single Site, Masked, Randomized, Controlled Study to Assess Efficacy of Osurdex as Adjunct to Avastin Compared With Avastin Alone in the Treatment of Patients With Macular Edema Due to Central or Branch Retinal Vein Occlusion
• Intravitreal Bevasizumab Versus Intravitreal Triamcinolone in Branch Retinal Vein Occlusion
• Lucentis for Macular Edema Associated With Central Retinal Vein Occlusion
• Safety and Efficacy of AGN208397 in the Treatment of Macular Edema Associated With Retinal Vein Occlusion (RVO)
• Ranibizumab in Patients With Branch Retinal Vein Occlusion
• Impact of Lucentis on Psychological Morbidity in Patients With Retinal Vein Occlusion
• Ranibizumab DosE Comparison and the Role of LAser in REtinal Vein Occlusions
• Safety and Effectiveness of Bevacizumab Intravitreal Injections in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion
• Study to Assess the Safety and Tolerability of a Single Administration of FOV2302 (Ecallantide) in Patients With Macular Edema Associated With Central Retinal Vein Occlusion
• Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)
• Effect of Intravitreal Ranibizumab Injection With Retinal Vein Occlusion (RVO)
• Bevacizumab for Central Retinal Vein Occlusion Study
• Posterior Vitreous Detachment (PVD) Assessment During Dual Retinal Vein Occlusion (RVO) Lucentis Evaluations
• Combined Triple Procedure in Retinal Vein Occlusion (RVO)
• Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in Retina
• Parnaparin vs Aspirin in the Treatment of Retinal Vein Occlusion
• A Randomized Study Comparing Ranibizumab to Sham in Patients With Macular Edema Secondary to CRVO
• Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO
• Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES)
• The ROVO Study: Radial Optic Neurotomy for CVO
• Atorvastatin for the Treatment of Retinal Vein Occlusion
• Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein Occlusions
• To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop to Treat Retinal Vein Occlusions
• A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO)
• A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRUISE)
• Ranibizumab (Lucentis) for Macular Edema Secondary to Vein Occlusions
• Lucentis for Central Retinal Vein Occlusion (CRVO)
• Rubeosis Anti-VEGF (RAVE) Trial for Ischemic Central Retinal Vein Occlusion
• Evaluation of Macugen Treatment of Macular Edema Due to Branch Retinal Vein Occlusion
• Intravitreal Ranibizumab Treatment of Central Retinal Vein Occlusion With Macular Edema
• Intravitreal Avastin Versus Intravitreal Avastin and Triamcinolone in Central Retinal Vein Occlusion(CRVO)
• Intravitreal Triamcinolone for Acute Branch Retinal Vein Occlusion
• A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion
• Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.).
• Treatment of Retinal Vein Occlusion (RVO) With Open-Label Anecortave Acetate (15mg.)
• A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion
• A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion
• Steroid Injections vs. Standard Treatment for Macular Edema Due to Retinal Blood Vessel Blockage
• The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study
• Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal Disorders
• Pegaptanib Sodium Compared to Sham Injection in Patients With Recent Vision Loss Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO)
• Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel Disorders
• Research Study in Patients With Persistent Macular Edema